This article explores the potential link between COVID-19 and parkinsonism, synthesizing existing evidence and recent research findings. It highlights limitations in current understanding, emphasizes the direct impact of the virus on dopamine neurons, and calls for continued research to elucidate long-term neurological implications and optimize patient care strategies.
Keywords: COVID-19; Neurological; Parkinsonism; SARS-CoV-2.
Copyright © 2024 Elsevier Ltd. All rights reserved.